Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19.
Erin GoerlichAnum S MinhasMonica MukherjeeFarooq H SheikhNisha A GilotraGarima V SharmaErin Donelly MichosAllison G HaysPublished in: Current cardiology reports (2021)
In addition to standard cardiac imaging techniques such as transthoracic echocardiography, other modalities including computed tomography and cardiac magnetic resonance imaging have emerged as useful adjuncts in select patients with COVID-19 infection, particularly those with suspected ischemic and nonischemic myocardial injury. Data have also emerged suggesting lasting COVID-19 subclinical cardiac effects, which may have long-term prognostic implications. With the spectrum of COVID-19 cardiovascular manifestations observed thus far, it is important for clinicians to recognize the role, strengths, and limitations of multimodality imaging techniques in this patient population.
Keyphrases
- computed tomography
- left ventricular
- magnetic resonance imaging
- high resolution
- coronavirus disease
- sars cov
- heart failure
- pulmonary embolism
- contrast enhanced
- positron emission tomography
- machine learning
- mass spectrometry
- electronic health record
- fluorescence imaging
- respiratory syndrome coronavirus
- pet ct
- data analysis